IXICO wins shareholder backing for equity raise but faces brief delay to share admission

The latest announcement is out from IXICO plc ( (GB:IXI) ).

IXICO plc said shareholders have approved all resolutions at a general meeting tied to its previously announced placings, subscription and retail offer, granting directors authority to allot new shares and implement a new non-employee sub-plan under its share option scheme. The votes clear key corporate approvals needed for the company’s equity fundraising, which is intended to strengthen its capital base as it continues to invest in its AI-led neuroimaging services.

However, the first and second admissions of the new ordinary shares to trading on AIM, originally expected later this week, are delayed pending receipt of Advance Assurance from HM Revenue & Customs under the UK Income Tax Act 2007. IXICO expects the assurance shortly and will publish a revised timetable ahead of long stop dates in mid-May, leaving investors monitoring timing risk but not, at this stage, the overall completion of the fundraising.

Spark’s Take on IXI Stock

According to Spark, TipRanks’ AI Analyst, IXI is a Neutral.

The score is held back primarily by weak financial performance (ongoing losses and negative operating cash flow) and very bearish technicals (below key moving averages with negative MACD). A positive offset comes from supportive earnings-call guidance and order book growth, but valuation remains constrained by the company’s loss-making profile.

To see Spark’s full report on IXI stock, click here.

More about IXICO plc

IXICO plc is a neuroscience-focused imaging and biomarker analytics company that operates as an imaging contract research organisation (iCRO) for the biopharmaceutical industry. Using its proprietary AI-driven platform, it supports global clinical trials in neurological disorders such as Alzheimer’s, Huntington’s and Parkinson’s disease, working with major pharma, biotech, consortia and non-profits to interpret complex brain imaging data.

Average Trading Volume: 167,485

Technical Sentiment Signal: Sell

Current Market Cap: £6.83M

For detailed information about IXI stock, go to TipRanks’ Stock Analysis page.